ACE2 and Thromboembolism: Indeed, recent literature has suggested that patients with SARS‐CoV‐2 are at higher risk of developing thromboembolisms, possibly mediated by the interaction with angiotensin‐converting enzyme 2 (ACE2) receptors.13